Pangaea Oncology, S.A. (BME:PANG)
1.470
0.00 (0.00%)
Nov 13, 2026, 4:00 PM CET
Pangaea Oncology Market Cap
Pangaea Oncology has a market cap or net worth of €52.84 million as of November 16, 2026. It is the 28,809th most valuable company in the world and the 171st biggest in Spain. Its market cap has decreased by 11.55% in one year.
Market Cap
52.84M
Enterprise Value
56.03M
Revenue
15.00M
Global Rank
Country Rank
#171 Spain
PE Ratio
n/a
ChartMarket Cap Chart
Since December 29, 2016, Pangaea Oncology's market cap has increased from 30.03M to 52.84M, an increase of 75.97%. That is a compound annual growth rate of 5.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 52.84M | -10.52% |
| Dec 31, 2025 | 59.05M | -2.89% |
| Dec 31, 2024 | 60.81M | 12.24% |
| Dec 29, 2023 | 54.18M | 8.35% |
| Dec 30, 2022 | 50.00M | 41.34% |
| Dec 30, 2021 | 35.38M | 30.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Grifols | 6.96B |
| Laboratorios Farmaceuticos Rovi | 3.54B |
| Almirall | 2.33B |
| Faes Farma | 1.58B |
| Laboratorio Reig Jofre | 213.40M |
| Prim, S.A. | 211.75M |
| Atrys Health | 202.67M |
| Oryzon Genomics | 192.28M |